On April 1, 2020, Sascha Alilovic was appointed Managing Partner of SHS. Since he joined SHS in 2018, SHS investors and portfolio companies have appreciated his expertise in the international life science industry and his experience in strategic transactions for national and international medical technology companies. For more information on Sascha Alilovic, click here.

The Red Dot Award is like the Oscar for product design. We would like to congratulate our portfolio company TRI® Dental Implants on its Red Dot Award for the world’s first digital implant matrix®. With this new kind of implant connection, dentists can plan the prosthetics for their patients directly on the implant, without an […]

The PiCSO® system is a milestone for heart attack patients and was awarded the coveted EU CE mark for medical products a few days ago. Every minute counts during a heart attack. Procedures undertaken in the cardiac catheter laboratory, where minimally invasive examinations and interventions on the heart are performed, are extremely challenging. Reducing the […]

Engineer Heinz Jacqui has successfully held management positions in international medical technology companies for more than 30 years. Since June 1, 2020, Heinz Jacqui has been bringing his strategic experience to bear at SHS by helping to review new portfolio companies in the fields of cardiology, imaging and intensive care. For more information on our […]

We’re sure some of you have already visited the new SHS website that went live in spring. Clearly structured and optimised for use on mobile devices, the new website contains information on our portfolio companies, investment strategy and investment funds and, of course, the latest news on all the activities of SHS and the companies […]

A real improvement in kidney transplant rejection diagnostics: The transplantation of a organ (e.g. kidney) is a highly invasive procedure, a high risk but also chance for the patient and a huge burden for the body to process. Furthermore, current standards of diagnosis for the rejection risk of transplanted kidneys are invasive, not robust, and an additonal burden for the patient. This is changing now by using NMR spectroscopy as a reliable and cost efficient non invasive alternative. Would it not be good to have access to such methodology as a standard?

At MedtecLIVE, which will take place virtually for the first time on 1 July, everything will revolve around the topic of financing in medical technology, with the aim of networking the players in the medical technology sector. The programme includes live streamed lectures, talks and pitches. Among others, SHS will also be present.

Heinz Jacqui (59) has been appointed Senior Advisor at SHS Gesellschaft für Beteiligungsmanagement effective June 1, 2020. By way of succession arrangements or growth financing, SHS specializes in investing in innovative healthcare companies that focus on medical technology and the life sciences. Through several funds, SHS has more than EUR 300 million under management. It […]

Miracor Medical SA (Miracor Medical) has announced the award of the CE Mark for its latest generation of PiCSO Impulse Catheter and PiCSO Impulse Console, which is indicated for the treatment of anterior STEMI patients. The new system features improvements in ease of use.

CE marking is expected for 2020 Submission at the FDA is expected for early 2021 On June 19, 2020, the Swiss Medtech company Advanced Osteotomy Tools (AOT) successfully completed the last surgery required for the first-in-man clinical study of its proprietary CARLO® device. The aim of the study was to demonstrate the performance and safety […]

FAZ reports on the SHS portfolio company Selfapy, which offers online therapies for depression, anxiety and eating disorders. This enables patients who need acute help to bridge long waiting times until a doctor’s appointment.

The M&A consultancy Clairfield and Luther Rechtsanwaltsgesellschaft prepared this informative study with the support of the German Medical Technology Association (BVMed) and the German Engineering Federation (VDMA). The study gives you an overview of the current development of medical technology in Germany, Europe, the USA and Asia: from a legal, technical and transaction-oriented perspective. Due […]